Recruiting PHASE3 INTERVENTIONAL 1-arm
NCT07461948
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Advanced MRI for Visualization and Quantification of the Tumor Immune Microenvironment (TIME) in Glioblastoma
Sponsor: Jonsson Comprehensive Cancer Center
Conditions
Glioblastoma
Interventions
Biospecimen Collection Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Diffusion-Relaxation Correlation Spectrum Imaging Electronic Health Record Review Ferumoxytol Magnetic Resonance Imaging
Updated 1 time since 2026 Last updated: Mar 6, 2026 Started: Oct 27, 2025 Primary completion: Oct 27, 2028 Completion: Oct 27, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Glioblastoma and is currently actively recruiting participants. Jonsson Comprehensive Cancer Center leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jonsson Comprehensive Cancer Center
- National Center for Advancing Translational Sciences (NCATS)
Data source: Jonsson Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .